111In[In]-BnDTPA-trastuzumab-NLS injection prepared from the kit was recently safely administered to 4 patients with HER2-positive BC to trace the uptake of trastuzumab into brain metastases enhanced by MRIg-FUS (Meng et al. 2021). Here, ERBB2 is linked to breast cancer.